Skip to main content
Journal of Virology logoLink to Journal of Virology
. 1995 Aug;69(8):4994–5010. doi: 10.1128/jvi.69.8.4994-5010.1995

Egress of varicella-zoster virus from the melanoma cell: a tropism for the melanocyte.

R Harson 1, C Grose 1
PMCID: PMC189316  PMID: 7609070

Abstract

The pathway of envelopment and egress of the varicella-zoster virus (VZV) and the primary site of viral production within the epidermal layer of the skin are not fully understood. There are several hypotheses to explain how the virus may receive an envelope as it travels to the surface of the monolayer. In this study, we expand earlier reports and provide a more detailed explanation of the growth of VZV in human melanoma cells. Human melanoma cells were selected because they are a malignant derivative of the melanocyte, the melanin-producing cell which originates in the neural crest. We were able to observe the cytopathic effects of syncytial formation and the pattern of egress of virions at the surfaces of infected monolayers by scanning electron microscopy and laser-scanning confocal microscopy. The egressed virions did not appear uniformly over the syncytial surface, rather they were present in elongated patterns which were designated viral highways. In order to document the pathway by which VZV travels from the host cell nucleus to the outer cell membrane, melanoma cells were infected and then processed for examination by transmission electron microscopy (TEM) at increasing intervals postinfection. At the early time points, within minutes to hours postinfection, it was not possible to localize the input virus by TEM. Thus, viral particles first observed at 24 h postinfection were considered progeny virus. On the basis of the TEM observations, the following sequence of events was considered most likely. Nucleocapsids passed through the inner nuclear membrane and acquired an envelope, after which they were seen in the endoplasmic reticulum. Enveloped virions within vacuoles derived from the endoplasmic reticulum passed into the cytoplasm. Thereafter, vacuoles containing nascent enveloped particles acquired viral glycoproteins by fusion with vesicles derived from the Golgi. The vacuoles containing virions fused with the outer plasma membrane and the particles appeared on the surface of the infected cell. Late in infection, enveloped virions were also present within the nuclei of infected cells; the most likely mechanism was retrograde flow from the perinuclear space back into the nucleus. Thus, this study suggests a role for the melanocyte in the pathogenesis of VZV infection, because all steps in viral egress can be accounted for if VZV subsumes the cellular pathways required for melanogenesis.

Full Text

The Full Text of this article is available as a PDF (9.9 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bowers R. R. The melanocyte of the chicken: a review. Prog Clin Biol Res. 1988;256:49–63. [PubMed] [Google Scholar]
  2. Brunovskis P., Velicer L. F. The Marek's disease virus (MDV) unique short region: alphaherpesvirus-homologous, fowlpox virus-homologous, and MDV-specific genes. Virology. 1995 Jan 10;206(1):324–338. doi: 10.1016/s0042-6822(95)80048-4. [DOI] [PubMed] [Google Scholar]
  3. Calnek B. W., Adldinger H. K., Kahn D. E. Feather follicle epithelium: a source of enveloped and infectious cell-free herpesvirus from Marek's disease. Avian Dis. 1970 May;14(2):219–233. [PubMed] [Google Scholar]
  4. Cheung P., Banfield B. W., Tufaro F. Brefeldin A arrests the maturation and egress of herpes simplex virus particles during infection. J Virol. 1991 Apr;65(4):1893–1904. doi: 10.1128/jvi.65.4.1893-1904.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cook M. K., Sears J. F. Preparation of infectious cell-free herpes-type virus associated with Marek's disease. J Virol. 1970 Feb;5(2):258–261. doi: 10.1128/jvi.5.2.258-261.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Davison A. J., Scott J. E. The complete DNA sequence of varicella-zoster virus. J Gen Virol. 1986 Sep;67(Pt 9):1759–1816. doi: 10.1099/0022-1317-67-9-1759. [DOI] [PubMed] [Google Scholar]
  7. Gershon A. A., Sherman D. L., Zhu Z., Gabel C. A., Ambron R. T., Gershon M. D. Intracellular transport of newly synthesized varicella-zoster virus: final envelopment in the trans-Golgi network. J Virol. 1994 Oct;68(10):6372–6390. doi: 10.1128/jvi.68.10.6372-6390.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gershon A., Cosio L., Brunell P. A. Observations on the growth of varicella-zoster virus in human diploid cells. J Gen Virol. 1973 Jan;18(1):21–31. doi: 10.1099/0022-1317-18-1-21. [DOI] [PubMed] [Google Scholar]
  9. Grose C., Brunel P. A. Varicella-zoster virus: isolation and propagation in human melanoma cells at 36 and 32 degrees C. Infect Immun. 1978 Jan;19(1):199–203. doi: 10.1128/iai.19.1.199-203.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Grose C., Perrotta D. M., Brunell P. A., Smith G. C. Cell-free varicella-zoster virus in cultured human melanoma cells. J Gen Virol. 1979 Apr;43(1):15–27. doi: 10.1099/0022-1317-43-1-15. [DOI] [PubMed] [Google Scholar]
  11. Grose C. The synthesis of glycoproteins in human melanoma cells infected with varicella-zoster virus. Virology. 1980 Feb;101(1):1–9. doi: 10.1016/0042-6822(80)90478-x. [DOI] [PubMed] [Google Scholar]
  12. Grose C. Variation on a theme by Fenner: the pathogenesis of chickenpox. Pediatrics. 1981 Nov;68(5):735–737. [PubMed] [Google Scholar]
  13. Jimbow K., Yamana K., Akutsu Y., Maeda K. Nature and biosynthesis of structural matrix protein in melanosomes: melanosomal structural protein as differentiation antigen for neoplastic melanocytes. Prog Clin Biol Res. 1988;256:169–182. [PubMed] [Google Scholar]
  14. Jones F., Grose C. Role of cytoplasmic vacuoles in varicella-zoster virus glycoprotein trafficking and virion envelopment. J Virol. 1988 Aug;62(8):2701–2711. doi: 10.1128/jvi.62.8.2701-2711.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Litwin V., Sandor M., Grose C. Cell surface expression of the varicella-zoster virus glycoproteins and Fc receptor. Virology. 1990 Sep;178(1):263–272. doi: 10.1016/0042-6822(90)90402-d. [DOI] [PubMed] [Google Scholar]
  16. Mishima Y., Ichihashi M., Hayashibe K., Ueda M., Hatta S., Funasaka Y., Imokawa G. Control of melanogenesis and melanoma oncogenesis. Prog Clin Biol Res. 1988;256:127–141. [PubMed] [Google Scholar]
  17. Montalvo E. A., Parmley R. T., Grose C. Structural analysis of the varicella-zoster virus gp98-gp62 complex: posttranslational addition of N-linked and O-linked oligosaccharide moieties. J Virol. 1985 Mar;53(3):761–770. doi: 10.1128/jvi.53.3.761-770.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Montalvo E. A., Parmley R. T., Grose C. Varicella-zoster viral glycoprotein envelopment: ultrastructural cytochemical localization. J Histochem Cytochem. 1986 Feb;34(2):281–284. doi: 10.1177/34.2.3003184. [DOI] [PubMed] [Google Scholar]
  19. Nii S. Aberrant forms of varicella-zoster virus. Biken J. 1973 Dec;16(4):173–176. [PubMed] [Google Scholar]
  20. Nii S. Electron microscopic study on the development of herpesviruses. J Electron Microsc (Tokyo) 1992 Dec;41(6):414–423. [PubMed] [Google Scholar]
  21. Nishioka K. Particulate tyrosinase of human malignant melanoma. Solubilization, purification following trypsin treatment, and characterization. Eur J Biochem. 1978 Apr;85(1):137–146. doi: 10.1111/j.1432-1033.1978.tb12221.x. [DOI] [PubMed] [Google Scholar]
  22. REYNOLDS E. S. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J Cell Biol. 1963 Apr;17:208–212. doi: 10.1083/jcb.17.1.208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. ROIZMAN B. Polykaryocytosis induced by viruses. Proc Natl Acad Sci U S A. 1962 Feb;48:228–234. doi: 10.1073/pnas.48.2.228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Rodriguez J. E., Moninger T., Grose C. Entry and egress of varicella virus blocked by same anti-gH monoclonal antibody. Virology. 1993 Oct;196(2):840–844. doi: 10.1006/viro.1993.1543. [DOI] [PubMed] [Google Scholar]
  25. Savage M. O., Moosa A., Gordon R. R. Maternal varicella infection as a cause of fetal malformations. Lancet. 1973 Feb 17;1(7799):352–354. doi: 10.1016/s0140-6736(73)90134-7. [DOI] [PubMed] [Google Scholar]
  26. Szilágyi J. F., Cunningham C. Identification and characterization of a novel non-infectious herpes simplex virus-related particle. J Gen Virol. 1991 Mar;72(Pt 3):661–668. doi: 10.1099/0022-1317-72-3-661. [DOI] [PubMed] [Google Scholar]
  27. WATSON M. L. Staining of tissue sections for electron microscopy with heavy metals. J Biophys Biochem Cytol. 1958 Jul 25;4(4):475–478. doi: 10.1083/jcb.4.4.475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. WELLER T. H. Serial propagation in vitro of agents producing inclusion bodies derived from varicella and herpes zoster. Proc Soc Exp Biol Med. 1953 Jun;83(2):340–346. doi: 10.3181/00379727-83-20354. [DOI] [PubMed] [Google Scholar]
  29. Weigle K. A., Grose C. Common expression of varicella-zoster viral glycoprotein antigens in vitro and in chickenpox and zoster vesicles. J Infect Dis. 1983 Oct;148(4):630–638. doi: 10.1093/infdis/148.4.630. [DOI] [PubMed] [Google Scholar]
  30. Whealy M. E., Card J. P., Meade R. P., Robbins A. K., Enquist L. W. Effect of brefeldin A on alphaherpesvirus membrane protein glycosylation and virus egress. J Virol. 1991 Mar;65(3):1066–1081. doi: 10.1128/jvi.65.3.1066-1081.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. van Genderen I. L., Brandimarti R., Torrisi M. R., Campadelli G., van Meer G. The phospholipid composition of extracellular herpes simplex virions differs from that of host cell nuclei. Virology. 1994 May 1;200(2):831–836. doi: 10.1006/viro.1994.1252. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES